22Dec 2024
Prevalence and Prescription of Antiobesity Medications in Healthcare

Prevalence and Prescription of Antiobesity Medications in Healthcare

Although nearly half of the eligible patients met the criteria for antiobesity medications (AOMs), only 1% received prescriptions. This cross-sectional study of over 2.4 million adults in the Mass General Brigham system found that 45% were eligible for AOMs, with musculoskeletal disorders being the most common obesity-related conditions. AOM prescriptions were more common in younger patients, those with higher BMI, and those with greater obesity-related conditions. Liraglutide and semaglutide were the most prescribed AOMs.

  • #endo-diabetology

Like

Save

Share